Clinical trials
Endometrial clinical trials
Below are recruiting endometrial clinical trials, each written for real people, not researchers. We’re tracking 363 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05510622Recruiting
Uterine microbiome study for recurrent pregnancy loss
This study looks at the normal bacteria and other microorganisms in the uterus to better understand recurrent pregnancy loss. You may be in a group with recurrent pregnancy loss or in a comparison group without pregnancy loss, and you’ll be asked to meet specific health and timing rules for samples.
Ho Chi Minh City, Ho Chi Minh CityAges 18–38 - NCT04619524Recruiting
Blood and lining tests during IVF cycles to guide endometrial timing
This study looks at “biomarkers” (test signals in your blood or cycle data) to better judge how ready the womb lining is during IVF. It compares two types of IVF hormone setups to see which approach best matches endometrial receptivity and supports successful embryo transfer.
Brno, South MoravianAges Up to 36 years - NCT05775211Recruiting
PBMC immune therapy added during fertility treatment
This trial studies whether giving your own immune cells (PBMC) to the uterus, modified with interferon (IFN‑t), can improve how endometrial (uterine lining) cells behave during infertility treatment. It may help some people with primary infertility who are undergoing assisted reproduction.
Sofia, SofiaAges 18–50 - NCT03651206RecruitingPhase 2/Phase 3
Study of niraparib and anti–PD-1 for recurrent uterine cancer
This trial studies whether blocking PD-1 (an immune “brake”) along with niraparib (a DNA-repair blocker) can shrink or control recurrent/progressive uterine carcinosarcoma after prior chemotherapy. It’s for people whose cancer has grown again and who meet specific health and lab requirements.
AngersAges 18 years+ - NCT07631572Recruiting
Cesium implant radiation for recurrent cervical or uterine cancer
This study tests a type of internal radiation (cesium implant) to treat cancer that has come back in the vagina after previous pelvic radiation. The goal is to save the organ while treating the cancer.
Lexington, KentuckyAges 18 years+ - NCT05760144RecruitingEarly Phase 1
Endometrial biopsy study in people using hormonal birth control
This early-phase study looks at doing an endometrial biopsy (a small tissue sample from the uterus) in people using a progestin-type contraceptive. It’s meant to test whether this approach works safely and how the uterus responds under these specific conditions.
Portland, OregonAges 18–40 - NCT06717802Recruiting
AI to predict when the womb is ready for IVF
This study uses artificial intelligence to find the best time to transfer an embryo during IVF. It may help people who have had up to 3 unsuccessful transfers before.
BudapestAges 18–40 - NCT07513493RecruitingPhase 4
Comparing two endometrial biopsy tools for women
This study compares two different devices used to collect tissue samples from the uterus (endometrial biopsy). Doctors use these samples to check for cancer or other problems when women have abnormal bleeding or other concerning symptoms. The trial will help determine which device works better and causes less discomfort.
Brooklyn, New YorkAges 18–95 - NCT07246733Recruiting
Royal jelly for ovarian function and uterine lining
This study tests whether a natural substance called royal jelly (a jelly produced by bees) can help improve how well your ovaries work and how your uterus lining responds. If you are a woman of childbearing age with regular periods, this trial may help understand if royal jelly can support fertility.
Yiwu, ZhejiangAges 20–45 - NCT06526962Recruiting
Comparing tools for removing uterine polyps
This study compares two methods to remove a single small uterine polyp during a hysteroscopy (a scope through the cervix). One method uses a thin bipolar electrode; the other uses a laser fiber. The goal is to see which works better and is safer.
CagliariAges 18–60 - NCT06859944Recruiting
Comparing two types of frozen embryo transfer preparation
This trial compares two ways to prepare the uterus for a frozen embryo transfer: a natural cycle or a new method using hormonal stimulation during the early part of the cycle. It may help improve success rates for people using their own eggs and sperm.
BrusselsAges 18–45 - NCT07494877Recruiting
Anticoagulant therapy for infertility in women aged 20-45
This study looks at whether blood-thinning medication can improve the chance of pregnancy in women who have trouble conceiving. It focuses on how the medication affects the lining of the womb and its ability to accept an embryo.
Xi'an, ShaanxiAges 20–45 - NCT06937645RecruitingPhase 2
Hyaluronic acid wash to improve pregnancy in IVF
This trial tests whether washing the uterus with hyaluronic acid before embryo transfer can improve pregnancy rates in women undergoing a fresh IVF cycle.
AL-Kadimya, Baghdad GovernorateAges 18–40 - NCT07606053Enrolling by invitation
Endometrial Microbiota and IVF Success
This study examines whether the bacteria living in the uterine lining (endometrium) affect whether embryos implant and pregnancies continue after IVF. Researchers will collect tissue samples and study your microbiota—the community of microorganisms in your body—to help explain repeated implantation failures or miscarriages.
ThessalonikiAges 18–54 - NCT07546825Recruiting
Minimally invasive versus open surgery for endometrial cancer staging
This trial compares two surgical approaches for treating endometrial cancer: traditional open surgery (laparotomy) versus minimally invasive keyhole surgery (laparoscopy). The goal is to determine which method is safer and more effective for removing the uterus, ovaries, and lymph nodes while staging the cancer.
AsyutAges Any age - NCT07499817RecruitingPhase 3
Effect of pentoxifylline on womb lining and frozen embryo transfer
This trial tests if a medication called pentoxifylline can help thicken the womb lining and improve success rates for frozen embryo transfers. It may be an option for people with a thin womb lining before their procedure.
Banī Suwayf, Beni Suweif GovernorateAges 18–43 - NCT05564377RecruitingPhase 2
Find targeted cancer treatments using genetic testing
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
Birmingham, AlabamaAges Any age - NCT07306559RecruitingPhase 1
Testing a new drug for advanced solid tumors
This trial tests different doses of a new drug (BI 3820768) in people with advanced solid tumors, specifically germ cell tumors, endometrial cancer, or ovarian cancer. The goal is to see if the drug is safe and how well it works.
Los Angeles, CaliforniaAges 18 years+ - NCT07419841RecruitingPhase 1
A study of CTX-10726 for certain advanced cancers
This trial tests a new drug called CTX-10726 in people with advanced kidney, liver, stomach, or uterine cancer that has not responded to standard treatments. The goal is to see if the drug is safe and tolerable.
Omaha, NebraskaAges 18 years+ - NCT04657068RecruitingPhase 1/Phase 2
Study of ART0380 for advanced solid tumors
This study tests a new drug called ART0380 for people with advanced solid tumors that have not responded to standard treatments. It may be especially helpful for those with certain DNA repair gene changes (like ATM or BRCA). The drug will be given alone or with chemotherapy (gemcitabine or irinotecan) depending on the part of the trial.
Birmingham, AlabamaAges 18 years+ - NCT05919264RecruitingPhase 1/Phase 2
FOG-001 for advanced solid tumors with certain gene changes
This trial tests a new drug, FOG-001, alone or with other treatments, for people with advanced solid tumors that have specific changes in the WNT pathway genes. It aims to see if the drug can shrink tumors or slow their growth.
Phoenix, ArizonaAges 18 years+ - NCT07705035RecruitingPhase 1
DBC-664 for adults with advanced solid tumors
This trial tests a new drug called DBC-664 for people with solid tumors that have come back or spread and cannot be removed by surgery. It may be an option if you have tried other treatments or if standard options are limited.
Grand Rapids, MichiganAges 18 years+ - NCT06974110RecruitingPhase 1
Study of a new drug for advanced solid tumors with MSI-H or dMMR
This trial tests an oral medication called MOMA-341 in people with advanced solid tumors that have high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR). It aims to see if the drug can help when prior immunotherapy hasn't worked or isn't available.
Phoenix, ArizonaAges 18 years+ - NCT05797168RecruitingPhase 1/Phase 2
Early study drug for advanced solid tumors, alone or with another drug
This Phase 1/2 study tests a new AstraZeneca cancer drug (AZD5335) to see how safely it can be given and how well it works in people with advanced solid tumors. You may get it alone or with another treatment, and you’ll need to provide tumor information (sometimes including a biopsy) for study planning.
Duarte, CaliforniaAges 18–130
Hear when a new Endometrial trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for endometrial?
- Yes. Clin2 currently lists 363 recruiting endometrial studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a endometrial trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a endometrial trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.